SOAT1 and Alzheimer disease: Although it could be theorized that these effects might be mediated by the JAK/STAT signaling, TNFα inhibitors have not been proven successful for the treatment of AD, and eczematous reactions have even been described under TNFα inhibitors treatment [52].